Xenometrix delivers innovative, reliable bioassays for the safety assessment of test compounds in mutagenesis, genotoxicity, endocrine activity and explants for absorption tests (IVPT), combining Swiss quality, scientific expertise, and customer-focused support for global research, regulatory needs.
Products, services, technology
Xenometrix offers bioassays for preclinical safety: Ames test (TG471, ICH M7), Micronucleus (MoA) - Test (TG487), chromosomal aberration (TG473), screening test for endocrine active chemicals, explants for IVPT (skin absorption). Service analytics support pharma, chemical, and cosmetic industries.
Cooperation possibilities
Assay and kit development for preclinical safety assessment, distribution of products used in preclinical in vitro safety testing. We are looking for a long term partnership and possible integration.
- https://www.xenometrix.ch
- +41 61 482 14 34
- Send an email
- Nicole Weiland
Some insights
Xenometrix offers test kits for the safety assessment of (agro)chemicals, pharmaceuticals, cosmetics, water to make the world a safer place. By miniaturization of Ames assays we reduce 9 x animal testing, 4 x quantity of test compound, 12 x contaminated plastic waste.
Xenometrix’s expertise is demonstrated by numerous scientific publications and its strong reputation in the research community. By miniaturizing assays, Xenometrix significantly reduces the use of test animals (S9 liver fraction), chemicals, contaminated waste, and plastic.
Our fast, efficient, and knowledgeable team delivers expert technical and scientific support, ensuring customers receive reliable guidance and solutions.
Customers, partners
